Cleerly’s James Min talks about heart disease and improving cardiovascular imaging at #HLTH2023

blonca9
Oct 8, 2023
1 min read

Dr. Min describes how Cleerly’s technology is designed to improve how CT scans are analyzed, and how the company aims to move upstream from symptomatic disease to doing asymptomatic screening as well.

Recent Posts

See All

As federal funding for cancer research has been jeopardized at NIH and academia, Parker Institute for Cancer Immunotherapy is one private institution ready to step up and broaden its impact

Mount Sinai has embraced AI as a drug discovery tool by launching this month its new AI Small Molecule Drug Discovery Center - Professor Avner Schlessinger tells us why

Jones Healthcare & Technology Innovation Conference: Jones Research analysts Soumit Roy and Justin Walsh share their take on biotech and comment on companies they cover

Cleerly’s James Min talks about heart disease and improving cardiovascular imaging at #HLTH2023

Recent Posts

Join the BiotechTV mailing list

Follow BiotechTV

Sponsors

Sponsor Spotlight